Adipocyte-specific mitochondrial intermediate peptidase (Mipep) deficiency protects against LPS-induced lethal inflammation through GDF15- and FGF21-independent mechanisms
Abstract
Sepsis is a life-threatening organ failure driven by an abnormally uncontrollable inflammatory response to systemic infection. Recent studies have demonstrated that mild mitochondrial stress confers protection against lipopolysaccharide (LPS)-induced septic shock; however, the precise mechanisms linking mitochondrial dysfunction to sepsis tolerance remain elusive. Here, we demonstrate that adipocyte-specific knockout of mitochondrial intermediate peptidase (MIPEP), termed aMKO, reduces susceptibility to LPS-induced mortality in mice. In MIPEP-deficient white adipose tissue (WAT), LPS-induced inflammatory responses were not uniform; selected proinflammatory and inflammasome-related responses were enhanced. By contrast, Mipep deficiency blunted the LPS-induced increase in circulating inflammatory cytokines. Consistent with this systemic attenuation, LPS-induced inflammatory cytokine expression was also less pronounced in nontargeted organs, including the liver, lungs, and spleen, where MIPEP remains intact. Although mitochondrial stress induces expression of growth differentiation factor 15 (GDF15) and fibroblast growth factor 21 (FGF21), which have been implicated in LPS tolerance, neither GDF15 deficiency nor pharmacological inhibition of FGF receptors affected the LPS resistance acquired in aMKO mice. Together, these findings suggest that MIPEP deficiency-induced remodeling of WAT inflammatory responses attenuates LPS-induced systemic cytokine amplification and lethal inflammation through mechanisms not fully dependent on endogenous GDF15 or FGF21.
Related
- Entamoeba histolytica Gal/GalNAc lectin intermediate subunit as a potential driver of inflammation and epithelial damage in intestinal amebiasis
- Independent linear association between flow-mediated dilation and predicted intermediate-to-high 10-year ASCVD risk in patients with type 2 diabetes: a retrospective study
- Distinct patterns of skeletal muscle wasting and mitochondrial changes following hypoxia and inflammation: associations with physiological phenotype
- Fagopyrum cymosum Extract Improves Mitochondrial Function and Reduces Colonic Inflammation in Ulcerative Colitis by Targeting the PI3K/Akt/FOXO3A Pathway
- Differential recovery of macrophage iron deficiency by oral iron formulations determines inflammation and autocrine hepcidin production in iron-deficiency anemia.
BibTeX
@article{fukuoh2026adipocytespecific,
title = {{Adipocyte-specific mitochondrial intermediate peptidase (Mipep) deficiency protects against LPS-induced lethal inflammation through GDF15- and FGF21-independent mechanisms}},
author = {Tomoyoshi Fukuoh and Yuka Nozaki and Kota Nagasawa and Shota Ayabe and Miku Yokoyama and Yuhei Mizunoe and Shuhei Ogawa and Shogo Okazaki and Ryo Goitsuka and Masaki Kobayashi and Yoshikazu Higami},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-75998-9},
url = {https://www.nature.com/articles/s41598-026-75998-9},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Adipocyte-specific mitochondrial intermediate peptidase (Mipep) deficiency protects against LPS-induced lethal inflammation through GDF15- and FGF21-independent mechanisms
AU - Tomoyoshi Fukuoh
AU - Yuka Nozaki
AU - Kota Nagasawa
AU - Shota Ayabe
AU - Miku Yokoyama
AU - Yuhei Mizunoe
AU - Shuhei Ogawa
AU - Shogo Okazaki
AU - Ryo Goitsuka
AU - Masaki Kobayashi
AU - Yoshikazu Higami
PY - 2026
DA - 2026/10/14
JO - Scientific Reports
DO - 10.1038/s41598-026-75998-9
UR - https://www.nature.com/articles/s41598-026-75998-9
AB - Sepsis is a life-threatening organ failure driven by an abnormally uncontrollable inflammatory response to systemic infection. Recent studies have demonstrated that mild mitochondrial stress confers protection against lipopolysaccharide (LPS)-induced septic shock; however, the precise mechanisms linking mitochondrial dysfunction to sepsis tolerance remain elusive. Here, we demonstrate that adipocyte-specific knockout of mitochondrial intermediate peptidase (MIPEP), termed aMKO, reduces susceptibility to LPS-induced mortality in mice. In MIPEP-deficient white adipose tissue (WAT), LPS-induced inflammatory responses were not uniform; selected proinflammatory and inflammasome-related responses were enhanced. By contrast, Mipep deficiency blunted the LPS-induced increase in circulating inflammatory cytokines. Consistent with this systemic attenuation, LPS-induced inflammatory cytokine expression was also less pronounced in nontargeted organs, including the liver, lungs, and spleen, where MIPEP remains intact. Although mitochondrial stress induces expression of growth differentiation factor 15 (GDF15) and fibroblast growth factor 21 (FGF21), which have been implicated in LPS tolerance, neither GDF15 deficiency nor pharmacological inhibition of FGF receptors affected the LPS resistance acquired in aMKO mice. Together, these findings suggest that MIPEP deficiency-induced remodeling of WAT inflammatory responses attenuates LPS-induced systemic cytokine amplification and lethal inflammation through mechanisms not fully dependent on endogenous GDF15 or FGF21.
SN - 2045-2322
ER -